简体中文

Professionals

YAO TingPartner

Tel::
+86 21 2415 5735
Fax:
+86 21 2422 4800
Email:
yaoting@anjielaw.com
Expertise:
Specialies in Private Equity Investment, M&A, Health Care& Life Sciences, and General Corporate Matters.
Information
    She has represented 5Y Capital (formally known as Morningside Venture Capital), Longhill Capital, Enlight Growth Partners, Kai Tai Capital, Matrix Partners, Panda Capital, Atlas Capital, Hong Kong and IFSC, Korea Investment Partners, Yuantai Evergreen Fund, Engage Capital, Steamboat Ventures, and We Doctor Group (formerly known as Guahao.com) in hundreds of transactions, covering a wide range of industries including smart manufacturing, medicine and healthcare, artificial intelligence, education, media and entertainment, new retail, semiconductors, new energy technology and financial technology, as well as representing fund clients in a large number of post-investment management and follow-on co-investments matters.
     
    She has represented a lot of companies in their financial or strategic financing and continues to provide day-to-day compliance legal service and innovative employee incentive plan services to clients. In her daily service to such clients, Ms. Yao has accumulated experience in general compliance, cybersecurity and data privacy service.

    Education
    Sun Yat-sen University, LL.B, 2013
    Shanghai Jiaotong University, LL.M, 2015

    Professional Qualification
    Admitted to practice in the PRC
Work Highlights
REPRESENTATIVE MATTERS AND CASES
 
  • Continuously represented Xiaozhu in its Series D and Series E financing, and strategic investment from Fliggy.
  • Continuously represented Ysbang in closing two rounds of Series C and Series D financing, with investors including Tiger Capital, H Capital, DCM, Shunwei Capital, SIG, Green Pine Capital and Gaojie Capital, and assisted Ysbang in completing the set-up of VIE structure.
  • Represented 5Y Capital in completing several rounds of investment in Xpeng Motors.
  • Represented 5Y Capital in completing Series B+, Series C and Series D investments in Hai Robotics.
  • Represented Yuantai Evergreen Fund to complete the Series D investment in Mafengwo.
  • Represented Silicon Intelligence in closing its Series C round of financing, with investors including Guoxin Central Enterprise Operating Fund, Ocean Pine Capital, Puxin Capital and Tencent.
  • Providing legal service to We Doctor Group for its Series C financing.
  • Represented Atlas Capital, 5Y Capital and Matrix Partners in closing the investment in Naxions, and continued to represent 5Y Capital in closing the subsequent investment in Naxions.
  • Represented Xiaotang in completing multiple rounds of funding.
  • Represented Suzhou Hanhua Semiconductor Co., Ltd. in closing a new round of financing of over 100 million RMB, with investors including Guangya Investment, China SME Development Fund Co., Ltd, Lextar Electronics, Huiqi Fund and China-Singapore Suzhou Industrial Park Industrial Investment Co., Ltd.
  • Represented China Yinyi Group in closing an investment in a cross-border healthcare agency registered in Delaware, USA.
  • Represented 5Y Capital in closing Series E and Series F financing in Tai Mei Medical Technology.
  • Represented Kaitai Capital in closing an investment in Auson Bio, an international biopharmaceutical company that develops and industrializes high-end modified formulations.
  • Represented Kaitai Capital in closing a strategic investment in Winhealth Pharma.
  • Represented IFSC in closing an investment in Beijing Huahao Zhongtian Biotechnology Company Limited, an innovative pharmaceutical company.
  • Represented Longhill Capital in completing its investment in an Internet-based Chinese medicine hospital.
  • Represented Applied Protein Technology in closing a new round of financing with nearly RMB 200 million.
  • Represented Korea Investment Partners and Yuantai Evergreen Fund in closing a Series B financing of an outbound travel company.
  • Represented Enlight Growth Partners in closing an investment in Apeman.
  • Represented Shanghai Angel Capital Guidance Fund in closing an investment in Whales Capital and New Access Capital.
  • Represented a Chinese insurance company in the settlement and remittance of investment capital gain from an offshore unicorn company in the travel industry to mainland China.
  • Continuously providing TMT compliance services to a multinational healthcare company and assisting it in applying its foreign value-added telecommunication business license application.
  • Providing cybersecurity and data legal compliance services for a well-known artificial intelligence company.
  • Providing legal compliance services to an Internet medical technology company.
  • Providing electronic signature legal compliance demonstration services for a multinational enterprise retailer.
Beijing Office

19/F, Tower D1, Liangmaqiao Diplomatic Office Building, No. 19 Dongfangdonglu, Chaoyang District, Beijing 100600

Tel:+86 10 8567 5988

Fax:+86 10 8567 5999

Shanghai Office

28/F, K.Wah Center,
No. 1010 Huaihai Road (M), Shanghai 200031

 

Tel:+86 21 2422 4888

Fax:+86 21 2422 4800

Shenzhen Office

38/F, Tower 3, Kerry Plaza,
No. 1-1 Zhongxinsi Road, Futian District, Shenzhen 518041

Tel:+86 755 8285 0609

Fax:+86 755 8285 0605

Follow us:

WeChat sweep
© 2016 - Copyright ANJIE - All Rights Reserved Designed by GreatMo